Publication of new paper on the anti-cancer properties of ivermectin prompted me to review the wondrous story of this wonder drug.
Hats off to Nicholas Hulscher, Peter McCullough, Harvey Risch et al. for their newly published paper on the anti-cancer properties of Ivermectin and Mebendazole.
Reading the study prompted me to review the fascinating story of Ivermectin — the wonder drug with a marvelously wide range of bioactive properties.
Increasingly I wonder if the “War on Ivermectin”—as Dr. Pierre Kory described the ferocious smear campaign that was waged by government health agencies against the compound—was not only to suppress ivermectin for the treatment of COVID-19, but also to sabotage general interest in how the cheap, off-label drug could be useful against other maladies such as cancer.
Those interested in learning more about the story of ivermectin and the nihilistic war that was waged against it may enjoy reading Chapter 12 of my book (with Peter A. McCullough, MD) The Courage to Face COVID-19.
